Rangarajan S - Search Results

1

Experience of four UK comprehensive care centres using FEIBA® for surgeries in patients with inhibitors.

Rangarajan S, Yee TT, Wilde J. Rangarajan S, et al. Haemophilia. 2011 Jan;17(1):28-34. doi: 10.1111/j.1365-2516.2010.02360.x. Haemophilia. 2011. PMID: 20642787

2

Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full-length FVIII treatment to B-domain-deleted r-FVIII and back to full-length FVIII.

Rea C, Dunkerley A, Sørensen B, Rangarajan S. Rea C, et al. Among authors: rangarajan s. Haemophilia. 2009 Nov;15(6):1237-42. doi: 10.1111/j.1365-2516.2009.02071.x. Epub 2009 Aug 2. Haemophilia. 2009. PMID: 19664015

3

Von Willebrand factor--two sides and the edge of a coin.

Rangarajan S. Rangarajan S. Haemophilia. 2011 Jan;17(1):61-4. doi: 10.1111/j.1365-2516.2010.02323.x. Haemophilia. 2011. PMID: 20518815

4

Inhibitors of coagulation.

Rangarajan S. Rangarajan S. Haemophilia. 2011 Jan;17(1):90-4. doi: 10.1111/j.1365-2516.2010.02335.x. Haemophilia. 2011. PMID: 20546027 No abstract available.

5

Molecular characterization of 11 novel mutations in patients with heterozygous and homozygous FV deficiency.

Cutler JA, Patel R, Rangarajan S, Tait RC, Mitchell MJ. Cutler JA, et al. Among authors: rangarajan s. Haemophilia. 2010 Nov;16(6):937-42. doi: 10.1111/j.1365-2516.2010.02330.x. Haemophilia. 2010. PMID: 20546033

6

Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.

Dai L, Bevan D, Rangarajan S, Sørensen B, Mitchell M. Dai L, et al. Among authors: rangarajan s. Haemophilia. 2011 Sep;17(5):e944-8. doi: 10.1111/j.1365-2516.2011.02491.x. Epub 2011 Mar 3. Haemophilia. 2011. PMID: 21371192

7

Three dominant-negative mutations in factor XI-deficient patients.

Dai L, Rangarajan S, Mitchell M. Dai L, et al. Among authors: rangarajan s. Haemophilia. 2011 Sep;17(5):e919-22. doi: 10.1111/j.1365-2516.2011.02519.x. Epub 2011 Apr 3. Haemophilia. 2011. PMID: 21457405

8

The international factor IX treatment network survey.

Berntorp E, Shapiro AD, Waters J, Astermark J; International Factor IX Treatment Network. Berntorp E, et al. Haemophilia. 2012 May;18(3):e60-2. doi: 10.1111/j.1365-2516.2012.02767.x. Epub 2012 Mar 8. Haemophilia. 2012. PMID: 22404549 No abstract available.

9

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.

Tengborn L, Baudo F, Huth-Kühne A, Knoebl P, Lévesque H, Marco P, Pellegrini F, Nemes L, Collins P; EACH2 registry contributors. Tengborn L, et al. BJOG. 2012 Nov;119(12):1529-37. doi: 10.1111/j.1471-0528.2012.03469.x. Epub 2012 Aug 20. BJOG. 2012. PMID: 22901076

10

Consensus recommendations for the use of FEIBA(®) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.

Rangarajan S, Austin S, Goddard NJ, Négrier C, Rodriguez-Merchan EC, Stephensen D, Yee TT. Rangarajan S, et al. Haemophilia. 2013 Mar;19(2):294-303. doi: 10.1111/hae.12028. Epub 2012 Sep 19. Haemophilia. 2013. PMID: 22989234 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

526 results

Search Page